Dr. Hollis Henry D'souza

InternshipK.E.M hospital2010 - 2011

Ad-Hoc Consultant /Specialist Registrar-Medical Oncology(Breast/ Gynaecology/Bone-Soft tissue/ Gastrointestinal Unit)Tata Memorial Hospital, Parel, Mumbai2020 - 2020

Specialist Registrar- and Unit Incharge Dept of Oncology –(On Deputation)Department of Oncology – B.K.L. Walawalkar Hospital , Chiplun Ratnagiri2019 - 2020

Senior Resident in General Medicine/ Medical OncologyBharat Ratna Dr.Babasaheb Ambedkar Memorial Hospital, Central Railways, Byculla, Mumbai2015 - 2016

Molecular tumor board: Case 1-Interplay of EGFR, MET and PD-L1 in non-small cell lung carcinoma.2019

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center2019

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.2017

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy2018

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer2019

Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real-world experience from a tertiary cancer center2019

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.2017

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy2018

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer2019

Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.2017

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy2018

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer2019

Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy2018

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.2019

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer2019

Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer2019

Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer2019

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer2020